BCG vaccine for clinically isolated syndrome and MS: infections and protective immunity

Neurology. 2014 Jan 7;82(1):15-6. doi: 10.1212/01.wnl.0000438232.40847.c3. Epub 2013 Dec 4.

Authors

Dennis Bourdette¹, Robert T Naismith

Affiliation

¹ From the Department of Neurology (D.B.), Oregon Health & Science University and Multiple Sclerosis Centers of Excellence-West, Veterans Affairs Medical Center, Portland; and the Department of Neurology (R.T.N.), Washington University, St. Louis, MO.

PMID: 24306000
DOI: 10.1212/01.wnl.0000438232.40847.c3

No abstract available

Publication types

Editorial
Comment

MeSH terms

BCG Vaccine / therapeutic use*
Brain / pathology*
Female
Humans
Male
Multiple Sclerosis / drug therapy*
Multiple Sclerosis / pathology*

Substances

BCG Vaccine